Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

One of NDM's units, The Jenner Institute, is to start clinical safety tests of a candidate Ebola vaccine, aimed at preventing the disease that has killed more than 1,200 people in the current outbreak in West Africa. The human trials of this vaccine are to be accelerated with international consortium funding in response to the Ebola epidemic. The World Health Organisation (WHO) has declared the outbreak a public health emergency of international concern.